Potential therapeutic applications of biosurfactants

Trends in Pharmacological Sciences

Volumn 34, Issue 12, 2013, Pages 667-675

  Gudiña, Eduardo J ^a   Rangarajan, Vivek ^b   Sen, Ramkrishna ^b   Rodrigues, Lígia R ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

antitumor agents; biosurfactants; drug delivery systems; therapeutic applications

Indexed keywords

ANTINEOPLASTIC AGENT; BIOSURFACTANT; GLYCEROL OLEATE; GLYCOLIPID; LIPOSOME; MANNOSYLERYTHRITOL LIPID; MEMBRANE LIPID; PHOSPHATIDYLCHOLINE; PROTEIN KINASE C; RHAMNOLIPID; SMALL INTERFERING RNA; SOPHOROLIPID; SPHINGOMYELIN; SUCCINOYL TREHALOSE LIPID; SURFACTIN; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BIOCOMPATIBILITY; CANCER INHIBITION; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MEMBRANE FLUIDITY; CELL MEMBRANE PERMEABILITY; CHROMATIN CONDENSATION; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HUMAN; MICELLIZATION; MICROEMULSION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTITUMOR AGENTS; BIOSURFACTANTS; DRUG DELIVERY SYSTEMS; THERAPEUTIC APPLICATIONS;

ANIMALS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; NEOPLASMS; SURFACE-ACTIVE AGENTS;

EID: 84889082286     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.10.002     Document Type: Review

References (72)

1. R. Marchant, and I.M. Banat Microbial biosurfactants: challenges and opportunities for future exploitation Trends Biotechnol. 30 2012 558 565
2. L. Fracchia Biosurfactants and bioemulsifiers biomedical and related applications: present status and future potentials D.N. Ghista, Biomedical Science, Engineering and Technology 2012 InTech 325 370
3. L.R. Rodrigues Inhibition of bacterial adhesion on medical devices D. Linke, A. Goldman, Bacterial Adhesion: Biology, Chemistry, and Physics, Series: Advances in Experimental Medicine and Biology 2011 Springer 351 367
4. J.D. Van Hamme Physiological aspects. Part 1 in a series of papers devoted to surfactants in microbiology and biotechnology Biotechnol. Adv. 24 2006 604 620
5. M. Sodagari Effect of rhamnolipids on initial attachment of bacteria on glass and octadecyltrichlorosilane-modified glass Colloids Surf. B: Biointerfaces 103 2013 121 128
6. P. Bharali Rhamnolipid (RL) from Pseudomonas aeruginosa OBP1: a novel chemotaxis and antibacterial agent Colloids Surf. B: Biointerfaces 103 2013 502 509
7. J.M. Raaijmakers Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics FEMS Microbiol. Rev. 34 2010 1037 1062
8. L.R. Rodrigues Biosurfactants: potential applications in medicine J. Antimicrob. Chemother. 57 2006 609 618
9. X.H. Cao Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway Chem. Biol. Interact. 183 2010 357 362
10. X. Zhao Treatment of mouse melanoma cells with phorbol 12-myristate 13-acetate counteracts mannosylerythritol lipid-induced growth arrest and apoptosis Cytotechnology 33 2000 123 130
11. H. Isoda, and T. Nakahara Mannosylerythritol lipid induces granulocytic differentiation and inhibits the tyrosine phosphorylation of human myelogenous leukemia cell line K562 Cytotechnology 25 1997 191 195
12. H. Isoda Succinoyl trehalose lipid induced differentiation of human monocytoid leukemic cell line U937 into monocyte-macrophages Cytotechnology 19 1995 79 88
13. D. Kitamoto Self-assembling properties of glycolipid biosurfactants and their potential applications Curr. Opin. Colloid Interface Sci. 14 2009 315 328
14. Y. Maitani Liposome vector containing biosurfactant-complexed DNA as herpes simplex virus thymidine kinase gene delivery system J. Liposome Res. 16 2006 359 372
15. M. Nakanishi Nano vectors with a biosurfactant for gene transfection and drug delivery J. Drug Deliv. Sci. Technol. 19 2009 165 169
16. M. Hosková Characterization of rhamnolipids produced by non-pathogenic Acinetobacter and Enterobacter bacteria Bioresour. Technol. 130 2013 510 516
17. H. Abbasi Interaction of a bacterial monorhamnolipid secreted by Pseudomonas aeruginosa MA01 with phosphatidylcholine model membranes Chem. Phys. Lipids 165 2013 745 752
18. H. Isoda Microbial extracellular glycolipid induction of differentiation and inhibition of protein kinase C activity of human promyelocytic leukaemia cell line HL60 Biosci. Biotechnol. Biochem. 61 1997 609 614
19. Y. Wakamatsu Mannosylerythritol lipid induces characteristics of neuronal differentiation in PC12 cells through an ERK related signal cascade Eur. J. Biochem. 268 2001 374 383
20. H. Isoda Differentiation of human promyelocytic leukemia cell line HL60 by microbial extracellular glycolipids Lipids 32 1997 263 271
21. V.K. Recke Lipase-catalyzed acylation of microbial mannosylerythritol lipids (biosurfactants) and their characterization Carbohydr. Res. 373 2013 82 88
22. T. Sudo Induction of the differentiation of human HL-60 promyelocytic leukemia cell line by succinoyl trehalose lipids Cytotechnology 33 2000 259 264
23. J. Chen Sophorolipid produced from the new yeast strain Wickerhamiella domercqiae induces apoptosis in H7402 human liver cancer cells Appl. Microbiol. Biotechnol. 72 2006 52 59
24. S.L. Fu Sophorolipids and their derivatives are lethal against human pancreatic cancer cells J. Surg. Res. 148 2008 77 82
25. L. Shao Bioactivities of sophorolipid with different structures against human esophageal cancer cells J. Surg. Res. 173 2012 286 291
26. C. Burgos-Díaz In vitro study of the cytotoxicity and antiproliferative effects of surfactants produced by Sphingobacterium detergens Int. J. Pharm. 453 2013 433 440
27. C. Sivapathasekaran Marine bacterium derived lipopeptides: characterization and cytotoxic activity against cancer cell lines Int. J. Pept. Res. Ther. 16 2010 215 222
28. S.Y. Kim Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression FEBS Lett. 581 2007 865 871
29. J.H. Lee The production of surfactin during the fermentation of Cheonggukjang by potential probiotic Bacillus subtilis CSY191 and the resultant growth suppression of MCF-7 human breast cancer cells Food Chem. 131 2012 1347 1354
30. 2+ is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosis Chem. Biol. Interact. 190 2011 16 27
31. X.H. Cao Evaluation of a lipopeptide biosurfactant from Bacillus natto Tk-1 as a potential source of anti-adhesive, antimicrobial and antitumor activities Braz. J. Microbiol. 40 2009 373 379
32. X.H. Cao Surfactin induces apoptosis and G2/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation Cell Biochem. Biophys. 55 2009 163 171
33. 2+-ERK pathways in HepG2 cells Cell Biochem. Biophys. 2013 10.1007/s12013-013-9676-7
34. N.A. El-Sersy Antibacterial and anticancer activity of É-poly-l-lysine (É-PL) produced by a marine Bacillus subtilis sp J. Basic Microbiol. 52 2012 513 522
35. C.L. Wang Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2 Peptide 28 2007 1344 1350
36. H.S. Saini Efficient purification of the biosurfactants viscosin from Pseudomonas libanensis strain M9-3 and its physicochemical and biological properties J. Nat. Prod. 71 2008 1011 1015
37. E. Escobar-Diaz AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B chronic lymphocytic leukemia cells: interference with the Akt/NF kB survival pathway Leukemia 19 2005 572 579
38. H.R. Seo Identification of Bacillus cereus in a Chungkukjang that showed high anticancer effects against AGS human gastric adenocarcinoma cells J. Med. Food 12 2009 1274 1280
39. P. Chiewpattanakul Bioproduction and anticancer activity of biosurfactant produced by the dematiaceous fungus Exophiala dermatitidis SK80 J. Microbiol. Biotechnol. 20 2010 1664 1671
40. E.J. Gudiña Isolation and functional characterization of a biosurfactant produced by Lactobacillus paracasei Colloids Surf. B: Biointerfaces 76 2010 298 304
41. A. Preetha Surface activity, lipid profiles and their implications in cervical cancer J. Cancer Res. Ther. 1 2005 180 186
42. M. Reynier Differences in lipid characteristics of undifferentiated and entercytic differentiated HT29 human colonic cells Cancer Res. 51 1991 1270 1277
43. M. Hilvo Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression Cancer Res. 71 2011 3236 3245
44. T.F. Bathen Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD Anticancer Res. 20 2000 2393 2408
45. J.L. Griffin, and J.P. Shockor Metabolic profiles of cancer cells Nat. Rev. Cancer 4 2004 551 561
46. S.A. Saddoughi Roles of bioactive sphingolipids in cancer biology and therapeutics Subcell. Biochem. 49 2008 413 440
47. T. Janek Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A375 cells by specific interaction with the plasma membrane PLoS ONE 8 2013 e57991
48. M. Fanun Microemulsions as delivery systems Curr. Opin. Colloid Interface Sci. 17 2012 306 313
49. M. Gangwar Recent advances in various emerging vesicular systems: an overview Asian Pac. J. Trop. Biomed. 2 2012 S1176 S1188
50. N. Anton, and T.F. Vandamme Nano-emulsions and micro-emulsions: clarifications of the critical differences Pharm. Res. 28 2011 978 985
51. D.J.A. Crommelin, and A.T. Florence Towards more effective advanced drug delivery systems Int. J. Pharm. 454 2013 496 511
52. J. Israelachvili The science and applications of emulsions - an overview Colloids Surf. A 91 1994 1 8
53. M.J. Lawrence, and G.D. Rees Microemulsion-based media as novel drug delivery systems Adv. Drug Deliv. Rev. 64 2012 175 193
54. B.K. Paul, and S.P. Moulik Uses and applications of microemulsions Curr. Sci. 80 2001 990 1001
55. L.D. Do Environmentally friendly vegetable oil microemulsions using extended surfactants and linkers J. Surfact. Deterg. 12 2009 91 99
56. K. Chansanroj, and G. Betz Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction Acta Biomater. 6 2010 3101 3109
57. E. Csizmazia Ibuprofen penetration enhance by sucrose ester examined by ATR-FTIR in vivo Pharm. Dev. Technol. 17 2012 125 128
58. P. Palanisamy Biosurfactant mediated synthesis of NiO nanorods Mater. Lett. 62 2008 743 746
59. M.L. Chen Solution self-assembly and adsorption at the air-water interface of the monorhamnose and dirhamnose rhamnolipids and their mixtures Langmuir 26 2010 18281 21829
60. H.Z. Gang Molecular dynamics study of surfactin monolayer at the air/water interface J. Phys. Chem. B 115 2011 12770 12777
61. J. Penfold Adsorption and self-assembly of biosurfactants studied by neutron reflectivity and small angle neutron scattering: glycolipids, lipopeptides and proteins Soft Matter 8 2012 578 591
62. H.H. Shen Surfactin structures at interfaces and in solution: the effect of pH and cations J. Phys. Chem. B 115 2011 4427 4435
63. Y. Xie Effect of alcohols on the phase behavior of microemulsions formed by a biosurfactant-rhamnolipid J. Dispers. Sci. Technol. 26 2005 455 461
64. S.S. Helvaci Effect of electrolytes on the surface behavior of rhamnolipids R1 and R2 Colloids Surf. B: Biointerfaces 35 2004 225 233
65. 1-40 J. Phys. Chem. B 112 2008 15195 15201
66. M. Malmsten Soft drug delivery systems Soft Matter 2 2006 760 769
67. T.T. Nguyen, and D.A. Sabatini Formulating alcohol-free microemulsions using rhamnolipid biosurfactant and rhamnolipid mixtures J. Surfact. Deterg. 12 2009 109 115
68. S.A. Onaizi Micellization and interfacial behavior of a synthetic surfactant-biosurfactant mixture Colloids Surf. A 415 2012 388 393
69. W. Worakitkanchanakul Formation of W/O microemulsion based on natural glycolipid biosurfactant J. Oleo Sci. 57 2008 55 59
70. T.T. Nguyen Biocompatible lecithin-based microemulsions with rhamnolipid and sophorolipid biosurfactants: formulation and potential applications J. Colloid Interface Sci. 348 2010 498 504
71. G.Y. Shim Cationic surfactin liposomes for enhanced cellular delivery of siRNA Asian J. Pharm. Sci. 4 2009 207 214
72. W.S. Cheow, and K. Hadinoto Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles Particuology 10 2012 327 333